Zhejiang Cheng Yi Pharmaceutical Co Ltd Sustainability Reports
The company researches, develops, manufactures, and markets active pharmaceutical ingredients (APIs), intermediates, and finished medical formulations including capsules and injections. Its primary products include glucosamine hydrochloride preparations and various generic medical treatments.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG001VCNXJ8
1 reports from 2024 to 2024